Pulmonology

Prof. Dr. İpek Candemir

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
DyspneaLung Diseases, InterstitialCOVID-19BronchiectasisHypertension, Pulmonary
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Dyspnea 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Diseases, Interstitial 3 publications
  • COVID-19 3 publications
  • Bronchiectasis 2 publications
  • Hypertension, Pulmonary 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workDyspneaExtracted from 7 publications · Model version —From source
  • Publications79 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-9877-3516ORCIDFrom source
  • Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-863757/klinik-doktorlarimiz.html#ipek-candemirsaglik.gov.tr

Scientific work

Publications on Dyspnea

79 publications

  1. Frequency of Radiologic Bronchiolocentric Interstitial Pneumonia Patterns and Associated Factors in Welders

    Canadian Respiratory Journal, 2026

    DOI 10.1155/carj/3335338 PMID 42803185 Open-access full textSource: ORCID

  2. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    2026

    DOI 10.2139/ssrn.6883835 Source: ORCID

  3. PREVALENCE AND CLINICAL CHARACTERISTICS OF LUNG CANCER IN ELDERY PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

    Turkish Journal of Geriatrics, 2026

    DOI 10.29400/tjgeri.2026.487 Open-access full textSource: ORCID

  4. Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potential

    Frontiers in Immunology, 2026

    DOI 10.3389/fimmu.2025.1731991 PMID 41601643 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10095928/v1 Open-access full textSource: OpenAlex

  6. Autoantibody Positivity in Patients with Hypersensitivity Pneumonitis: A Subgroup Analysis of the TURK-HP Study Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa1967 Source: OpenAlex

  7. Antifibrotic Use in Hypersensitivity Pneumonitis: Real-World Data from a Subgroup Analysis of the TURK-HP Cohort

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6288 Source: OpenAlex

  8. Trunk muscle thickness is associated with respiratory muscle function and peak exercise capacity in COPD

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa643 Source: OpenAlex

  9. Regional Differences in Exposure Histories Among Patients Diagnosed with Hypersensitivity Pneumonitis: A Subgroup Analysis of TURK-HP Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa6287 Source: OpenAlex

  10. Predictors of Diffusion Capacity through Cardiopulmonary Exercise Testing Parameters in Patients with Fibrotic Interstitial Lung Disease: A Pilot Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2692 Source: OpenAlex

View all 79 publications